Holen Sie sich die Stockscreener-App
7.59
0.26%
0.02
Handel nachbörslich:
7.47
-0.12
-1.58%
Finanzdaten der Xeris Biopharma Holdings Inc-Aktie (XERS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
19.00%
71.54
|
60.12 | 60.10 | 54.27 | 48.06 |
Operating Expenses
|
6.09%
67.06
|
63.21 | 58.42 | 67.16 | 56.25 |
| Benefits Costs and Expenses |
-
|
- | 260.17 | - | - |
| Costs And Expenses |
6.09%
67.06
|
63.21 | 81.88 | 67.16 | 56.25 |
| Operating Income/Loss |
245.05%
4.482
|
-3.09 | 1.679 | -12.89 | -8.187 |
| Income/Loss From Continuing Operations Before Tax |
875.91%
71.54
|
-9.22 | -200.07 | 54.27 | -15.01 |
| Income Tax Expense/Benefit, Deferred |
-
|
- | - | -3.324 | 0.749 |
| Income Tax Expense/Benefit |
-
|
- | - | -3.324 | 0.749 |
| Income/Loss From Continuing Operations After Tax |
79.09%
-1.928
|
-9.22 | -5.113 | -15.74 | -15.01 |
|
Net Income/Loss
|
79.09%
-1.928
|
-9.22 | -5.113 | -15.74 | -15.01 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
4.60%
159.46
|
152.45 | 0.8106 | 148.99 | 148.35 |
| Diluted Average Shares |
4.60%
159.46
|
152.45 | 0.8106 | 148.99 | 148.35 |
| Basic Earnings Per Share |
83.33%
-0.01
|
-0.06 | -0.03 | -0.11 | -0.10 |
| Diluted Earnings Per Share |
83.33%
-0.01
|
-0.06 | -0.03 | -0.11 | -0.10 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.55%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):